HIV/AIDS

Top Story

HIV drugs raltegravir, efavirenz similar in AIDS, mortality outcomes

May 24, 2017

A regimen containing the integrase inhibitor raltegravir yielded AIDS and overall mortality outcomes similar to one containing efavirenz in patients with HIV, according to researchers.

“Given favorable short-term virologic control, integrase inhibitor-containing regimens have become the preferred initial treatment options in many resource-rich countries, such as the United States,” Stephen R. Cole, PhD, a professor of epidemiology at the University of North Carolina, Chapel Hill, and colleagues wrote in Clinical Infectious Diseases. “However, there has not yet been extensive investigation of longer term comparative effectiveness, especially in terms of clinical endpoints such as HIV disease progression or mortality.”

In the Journals Plus

Despite model ART program, advanced HIV persists in Botswana

May 24, 2017
Although Botswana has a widely available national ART program, advanced HIV disease remains a significant burden because the program is failing to link people to care…
In the Journals Plus

PrEP use consistent with CDC guidelines may reduce STIs among MSM

May 23, 2017
The use of pre-exposure prophylaxis, or PrEP, for HIV prevention in addition to routine screening and treatment of sexually transmitted infections could reduce the…
In the Journals

Hepatic steatosis worsens faster in HIV mono-infection than HIV/HCV

May 22, 2017
Hepatic steatosis progressed faster and was more often associated with liber fibrosis progression among patients with HIV mono-infection compared with patients with…
CME CE CNE CPE CPE

HIV/AIDS 1 Hour Update For Florida Health Professionals

No commercial support for this activity.

This is a 1 hour activity designed for home study by healthcare clinicians. Specifically, it meets the 1 hour HIV/AIDS…
More »
In the Journals Plus

Record levels of in-home HIV test sales linked to the ‘Charlie Sheen effect’

May 18, 2017
After actor Charlie Sheen announced that he was HIV-positive during an interview on NBC’s Today Show on Nov. 17…
More »
Featured
Conference on Retroviruses and Opportunistic Infections (CROI)

Conference on Retroviruses and Opportunistic Infections (CROI)

Video
Meeting News

VIDEO: Carlos del Rio, MD, discusses HIV epidemiology, prevention

November 1, 2016
More »
In the Journals Plus

HIV drugs raltegravir, efavirenz similar in AIDS, mortality outcomes

May 24, 2017
A regimen containing the integrase inhibitor raltegravir yielded AIDS and overall mortality outcomes similar to one containing efavirenz in patients…

In the Journals Plus

Despite model ART program, advanced HIV persists in Botswana

May 24, 2017
Although Botswana has a widely available national ART program, advanced HIV disease remains a significant burden because the program is failing to…

In the Journals Plus

PrEP use consistent with CDC guidelines may reduce STIs among MSM

May 23, 2017
The use of pre-exposure prophylaxis, or PrEP, for HIV prevention in addition to routine screening and treatment of sexually transmitted infections…

In the Journals

Hepatic steatosis worsens faster in HIV mono-infection than HIV/HCV

May 22, 2017
Hepatic steatosis progressed faster and was more often associated with liber fibrosis progression among patients with HIV mono-infection compared…

In the Journals Plus

Transmission of HIV drug resistance increases among illegal drug users in Vancouver

May 19, 2017
The prevalence of transmitted drug resistance in people with HIV who were using illegal drugs increased significantly over a 20-year period in…

In the Journals Plus

Record levels of in-home HIV test sales linked to the ‘Charlie Sheen effect’

May 18, 2017
After actor Charlie Sheen announced that he was HIV-positive during an interview on NBC’s Today Show on Nov. 17, 2015, researchers found that…

Top stories for HIV Vaccine Awareness Day

May 18, 2017
The first HIV vaccine clinical trial was launched in 1987 at the NIH Clinical Center in Bethesda, Maryland, according to the HHS. Thirty years later…

WHO: Nearly half of deaths worldwide now have recorded cause

May 17, 2017
Of the estimated 56 million deaths recorded globally in 2015, approximately 27 million were registered with a cause, according to data from…

In the Journals Plus

Stock market models accurately predict changes in HIV over time

May 17, 2017
Mathematical models that were originally developed to predict changes in stock prices accurately predicted changes in the properties of HIV

Cryptococcal meningitis causes 15% of AIDS–related deaths globally

May 15, 2017
Cryptococcal meningitis caused an estimated 15% of AIDS–related deaths globally in 2014 but remains a neglected factor in the response to the…

More Headlines »
Advertisement
Advertisement